CDXC Launch TRU NIAGEN® in New Zealand with Partner Matakana
Aug 8, 2018 10:44:02 GMT
icemandios, thought013, and 1 more like this
Post by tomsylver on Aug 8, 2018 10:44:02 GMT
ChromaDex to Launch TRU NIAGEN® in New Zealand with Retail Partner Matakana SuperFoods
Wed August 8, 2018 6:30 AM|GlobeNewswire|About: CDXC
GlobeNewswire
IRVINE, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®, announced today the appointment of Matakana Superfoods (MSF) as the exclusive distributor of TRU NIAGEN in New Zealand.
The sole active ingredient in TRU NIAGEN is nicotinamide riboside, a unique form of vitamin B3 clinically proven to safely increase one’s levels of NAD (nicotinamide adenine dinucleotide). Decreased NAD levels have been associated with many age-related changes in overall health.
“We will continue the worldwide expansion of TRU NIAGEN and are selecting territories based on economics as well as strategic learnings,” says Robert Fried, CEO of ChromaDex (CDXC).
MSF is an established dietary supplement manufacturer and distributor in New Zealand with national distribution in both online and offline channels. The company has more than 70 lines of superfood products.
Kevin Glucina, founder and CEO of MSF remarked, “We are very excited to be appointed exclusive distributors of this world-first, science backed, healthy aging breakthrough. As one of the first countries in the world to receive TRU NIAGEN, we feel privileged to be able to offer this revolutionary supplement to the people of New Zealand. Fundamental breakthroughs in cellular health don’t come along every day and we are sure TRU NIAGEN will benefit our aging population.”
“We are delighted to have MSF as our distribution partner in NZ and look forward to introducing TRU NIAGEN to the consumers in Oceania very soon,” added Will Black, VP Sales and Marketing at ChromaDex.
The launch of TRU NIAGEN in New Zealand is expected in mid-September 2018.
For more information on Matakana SuperFoods and its products, visit www.matakanasuperfoods.com.
About TRU NIAGEN®:
TRU NIAGEN® is a branded dietary supplement brought to market by key nicotinamide riboside innovator and patent holder, ChromaDex. NIAGEN® nicotinamide riboside (NR), also supplied by ChromaDex, is the sole active ingredient in TRU NIAGEN®. Multiple clinical trials demonstrate NIAGEN® is proven to boost NAD (nicotinamide adenine dinucleotide) levels, which decline with age. Only NIAGEN® has twice been successfully reviewed under FDA's new dietary ingredient (“NDI”) notification program, and has also been successfully notified to the FDA as generally recognized as safe (“GRAS”).
About ChromaDex:
ChromaDex Corp. is an integrated, global nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.
Wed August 8, 2018 6:30 AM|GlobeNewswire|About: CDXC
GlobeNewswire
IRVINE, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®, announced today the appointment of Matakana Superfoods (MSF) as the exclusive distributor of TRU NIAGEN in New Zealand.
The sole active ingredient in TRU NIAGEN is nicotinamide riboside, a unique form of vitamin B3 clinically proven to safely increase one’s levels of NAD (nicotinamide adenine dinucleotide). Decreased NAD levels have been associated with many age-related changes in overall health.
“We will continue the worldwide expansion of TRU NIAGEN and are selecting territories based on economics as well as strategic learnings,” says Robert Fried, CEO of ChromaDex (CDXC).
MSF is an established dietary supplement manufacturer and distributor in New Zealand with national distribution in both online and offline channels. The company has more than 70 lines of superfood products.
Kevin Glucina, founder and CEO of MSF remarked, “We are very excited to be appointed exclusive distributors of this world-first, science backed, healthy aging breakthrough. As one of the first countries in the world to receive TRU NIAGEN, we feel privileged to be able to offer this revolutionary supplement to the people of New Zealand. Fundamental breakthroughs in cellular health don’t come along every day and we are sure TRU NIAGEN will benefit our aging population.”
“We are delighted to have MSF as our distribution partner in NZ and look forward to introducing TRU NIAGEN to the consumers in Oceania very soon,” added Will Black, VP Sales and Marketing at ChromaDex.
The launch of TRU NIAGEN in New Zealand is expected in mid-September 2018.
For more information on Matakana SuperFoods and its products, visit www.matakanasuperfoods.com.
About TRU NIAGEN®:
TRU NIAGEN® is a branded dietary supplement brought to market by key nicotinamide riboside innovator and patent holder, ChromaDex. NIAGEN® nicotinamide riboside (NR), also supplied by ChromaDex, is the sole active ingredient in TRU NIAGEN®. Multiple clinical trials demonstrate NIAGEN® is proven to boost NAD (nicotinamide adenine dinucleotide) levels, which decline with age. Only NIAGEN® has twice been successfully reviewed under FDA's new dietary ingredient (“NDI”) notification program, and has also been successfully notified to the FDA as generally recognized as safe (“GRAS”).
About ChromaDex:
ChromaDex Corp. is an integrated, global nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.